COMORBIDITY-BASED EQ-5D SCORES OF PRIMARY CARE PATIENTS IN FINLAND, THEIR POTENTIAL TO BENEFIT AND UNMET MEDICAL NEED

Author(s)

Soini EJ1, Heinonen J2, Miettola E2, Ryynänen O3, Koskela T4
1ESIOR Oy, Kuopio, Finland, 2School of Medicine, University of Tampere, Finland, 3Faculty of Health Sciences, University of Eastern Finland, and Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, 4Department of General Practice, University of Tampere, and Omapihlaja, Pihlajalinna Terveys Oy, Tampere, Finland

OBJECTIVES:  Comorbidity-based health-related quality of life (HRQoL) scores from primary health care setting (PHCS) are needed frequently in the initiation of cost-utility simulation modelling. Yet, PHCS HRQoL studies and scores are rare – general population-based or specialist care setting HRQoL scores are more frequently available. We study PHCS HRQoL comorbidity-based. We also estimate the baseline potential to benefit (PTB) and 3-months unmet medical need (UMN) by applying a matched-adjusted indirect comparison (MAIC), which was developed by us to predict the multivariate matched general population control (MGPC) HRQoL scores at individual level. METHODS:  Unselected PHCS patients (N 519) filled EQ-5D-3L questionnaire (British preferences) during Effective Health Centre Study in three Finnish health centres located in Pirkanmaa. 0.07 was considered to be the minimum clinically important difference (MID). Stata MP 14.1 was used. RESULTS:  0.74 and 0.78 mean baseline and three month EQ-5D-3L scores were observed, respectively. The lowest (0.54, 0.54 or 0.63) mean baseline scores were observed for patients with neck, back or neurologic comorbidity, respectively. Patients with diabetes, hypertension or coronary heart disease had the highest respective (0.75, 0.74 or 0.74) mean baseline scores. Patients with no, 1, 2, 3, 4 and 5 or more comorbidities had 0.82 (0.91), 0.75 (0.86), 0.74 (0.76), 0.73 (0.75), 0.69 (0.67) and 0.50 (0.53) scores at the baseline (three months), respectively. The highest and lowest PTB at baseline was estimated for patients with one and four comorbidities, respectively. Patients with 5 or more comorbidities and no comorbidity had the highest and lowest UMN at three months, respectively. MID UMN was observed for heart failure, asthma, neurologic disease or inflammatory bowel disease patients. CONCLUSIONS: PHCS HRQoL scores are needed. The UMN seems to increase as the function of comorbidity. Yet, the PTB decreases as the function of comorbidity. Patients presenting with some spesific comorbidities had potentially persistent residual disutility.

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PHP226

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×